Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats

Cell Transplantation

Volumn 10, Issue 4-5, 2001, Pages 397-401

  Date, I ^a   Shingo, T ^a   Yoshida, H ^a   Fujiwara, K ^a   Kobayashi, K ^a   Takeuchi, A ^a   Ohmoto, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Encapsulation; Glial cell line derived neurotrophic factor GDNF); Neural transplantation; Parkinson's disease

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL SURVIVAL; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; ENCAPSULATION; GENETIC ENGINEERING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0034874180     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000001783986486     Document Type: Conference Paper

References (15)

1. Long-term cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell line
2. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: Behavioral and histological studies using two different dosages
3. GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration
4. GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice
5. Long-term effect of MPTP in the mouse brain in relation to aging: Neuro-chemical and immunocytochemical analysis
6. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats
7. Chromaffin cell survival from both young and old donors is enhanced by cografts of polymer-encapsulated human NGF-secreting cells
8. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells
9. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study
10. A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy
11. Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: A behavioral, neuroanatomical, and neurochemical analysis
12. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
13. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle
14. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine
15. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates